| Isolation of multipotent cells from human term placenta BL Yen, HI Huang, CC Chien, HY Jui, BS Ko, M Yao, CT Shun, M Yen, ... Stem cells 23 (1), 3-9, 2005 | 624 | 2005 |
| AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations JL Tang, HA Hou, CY Chen, CY Liu, WC Chou, MH Tseng, CF Huang, ... Blood, The Journal of the American Society of Hematology 114 (26), 5352-5361, 2009 | 407 | 2009 |
| The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles DM Huang, JK Hsiao, YC Chen, LY Chien, M Yao, YK Chen, BS Ko, ... Biomaterials 30 (22), 3645-3651, 2009 | 382 | 2009 |
| TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics WC Chou, SC Chou, CY Liu, CY Chen, HA Hou, YY Kuo, MC Lee, BS Ko, ... Blood, The Journal of the American Society of Hematology 118 (14), 3803-3810, 2011 | 380 | 2011 |
| Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking DM Huang, Y Hung, BS Ko, SC Hsu, WH Chen, CL Chien, CP Tsai, ... The FASEB journal 19 (14), 2014-2016, 2005 | 362 | 2005 |
| DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications HA Hou, YY Kuo, CY Liu, WC Chou, MC Lee, CY Chen, LI Lin, MH Tseng, ... Blood, The Journal of the American Society of Hematology 119 (2), 559-568, 2012 | 292 | 2012 |
| Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations WC Chou, HH Huang, HA Hou, CY Chen, JL Tang, M Yao, W Tsay, BS Ko, ... Blood, The Journal of the American Society of Hematology 116 (20), 4086-4094, 2010 | 262 | 2010 |
| The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia WC Chou, WC Lei, BS Ko, HA Hou, CY Chen, JL Tang, M Yao, W Tsay, ... Leukemia 25 (2), 246-253, 2011 | 206 | 2011 |
| WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system HA Hou, TC Huang, LI Lin, CY Liu, CY Chen, WC Chou, JL Tang, ... Blood, The Journal of the American Society of Hematology 115 (25), 5222-5231, 2010 | 198 | 2010 |
| The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells YC Chen, JK Hsiao, HM Liu, IY Lai, M Yao, SC Hsu, BS Ko, YC Chen, ... Toxicology and applied pharmacology 245 (2), 272-279, 2010 | 194 | 2010 |
| RUNX1 gene mutation in primary myelodysplastic syndrome – the mutation can be detected early at diagnosis or acquired during disease progression and is … CY Chen, LI Lin, JL Tang, BS Ko, W Tsay, WC Chou, M Yao, SJ Wu, ... British journal of haematology 139 (3), 405-414, 2007 | 172 | 2007 |
| TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution HA Hou, WC Chou, YY Kuo, CY Liu, LI Lin, MH Tseng, YC Chiang, ... Blood cancer journal 5 (7), e331-e331, 2015 | 160 | 2015 |
| The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution SJ Wu, YY Kuo, HA Hou, LY Li, MH Tseng, CF Huang, FY Lee, MC Liu, ... Blood, The Journal of the American Society of Hematology 120 (15), 3106-3111, 2012 | 159 | 2012 |
| Genetic alterations and their clinical implications in older patients with acute myeloid leukemia CH Tsai, HA Hou, JL Tang, CY Liu, CC Lin, WC Chou, MH Tseng, ... Leukemia 30 (7), 1485-1492, 2016 | 127 | 2016 |
| IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease … CC Lin, HA Hou, WC Chou, YY Kuo, CY Liu, CY Chen, YJ Lai, MH Tseng, ... American journal of hematology 89 (2), 137-144, 2014 | 109 | 2014 |
| Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome TC Chen, HA Hou, WC Chou, JL Tang, YY Kuo, CY Chen, MH Tseng, ... Blood cancer journal 4 (1), e177-e177, 2014 | 106 | 2014 |
| Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia HA Hou, CC Lin, WC Chou, CY Liu, CY Chen, JL Tang, YJ Lai, MH Tseng, ... Leukemia 28 (1), 50-58, 2014 | 105 | 2014 |
| Cyclooxygenase-2-Derived Prostaglandin E2 Protects Mouse Embryonic Stem Cells from Apoptosis JY Liou, DP Ellent, S Lee, J Goldsby, BS Ko, N Matijevic, JC Huang, ... Stem Cells 25 (5), 1096-1103, 2007 | 97 | 2007 |
| Clinical and microbiological characteristics of perianal infections in adult patients with acute leukemia CY Chen, A Cheng, SY Huang, WH Sheng, JH Liu, BS Ko, M Yao, ... PloS one 8 (4), e60624, 2013 | 96 | 2013 |
| Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia–the occurrence of retinoic acid syndrome is a risk factor BS Ko, JL Tang, YC Chen, M Yao, CH Wang, MC Shen, HF Tien Leukemia 13 (9), 1406-1408, 1999 | 96 | 1999 |
